TrialCancer research and treatment2016

Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial.

Jin Hyoung Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.